Pediatric Hematologist/Oncologist (Child Cancer Specialist)
Brian Stover, MD, earned his medical degree from the University of Texas Medical School at Houston. Soon after, he began his residency in pediatrics at the University of Florida and continued his career at UF, completing a fellowship in pediatric hematology/oncology.
Dr. Stover joined the UF faculty in 2019 as an assistant professor in the department of pediatrics. His current research focuses on solid tumor immunotherapy, including the use of personalized RNA-nanoparticle vaccines in metastatic osteosarcoma.
Dr. Stover is board-certified in pediatrics by the American Board of Pediatrics and is board-eligible in hematology/oncology. He is a recipient of the Henry A. Kokomoor award for Scientific Discovery and is a member of the American Academy of Pediatrics, the Children’s Oncology Group and the American Society of Pediatric Hematology-Oncology.
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesThis phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in children, and FHWT is the most common subtype.…
This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with an alkylating agents. Alkylating agents are part of standard…
This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that is growing, spreading, or getting worse (progressive), has come back (relapsed) after…
“Make sure you fight." Jennifer Driggers uttered those four words to her daughter the day after Julianna was diagnosed with neuroblastoma, an aggressive form…
